tiprankstipranks
Biocept, Inc. (BIOCQ)
:BIOCQ
US Market

Biocept (BIOCQ) Income Statement

Compare
1,247 Followers

Biocept Income Statement

Last quarter (Q2 2023), Biocept's total revenue was $589.00K, a decrease of -12.48% from previous quarter. In Q2, Biocept's net income was $-3.63M. See Biocept’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.86M$ 61.25M$ 27.46M$ 5.53M
Gross Profit
$ -2.58M$ 23.48M$ 6.12M$ -5.45M
Operating Expenses
$ 29.40M$ 25.89M$ 21.59M$ 17.61M
Depreciation and Amortization
$ 1.66M$ 1.53M$ 1.00M$ 773.31K
EBITDA
$ -30.24M$ -879.00K$ -16.57M$ -24.11M
Operating Income
$ -31.98M$ -2.41M$ -15.47M$ -23.06M
Other Income/Expenses
$ -229.00K$ -290.00K$ -2.34M$ -2.08M
Pretax Income
$ -32.21M$ -2.70M$ -17.81M$ -25.14M
Net Income
$ -32.09M$ -2.82M$ -17.81M$ -25.14M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -56.78$ -5.73$ -45.10$ -365.01
Diluted EPS
$ -56.78$ -5.73$ -45.10$ -365.01
Weighted Average Shares Outstanding
565.13K 492.53K 394.84K 68.87K
Weighted Average Shares Outstanding (Diluted)
565.13K 492.53K 394.84K 68.87K
Currency in USD

Biocept Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis